<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Environ Health Perspect</journal-id><journal-title-group><journal-title>Environmental Health Perspectives</journal-title></journal-title-group><issn pub-type="ppub">0091-6765</issn><issn pub-type="epub">1552-9924</issn><publisher><publisher-name>National Institute of Environmental Health Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1289/ehp.0800370</article-id><article-id pub-id-type="publisher-id">ehp-117-1373</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Modification of the Interleukin-6 Response to Air Pollution by Interleukin-6 and Fibrinogen Polymorphisms</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ljungman</surname><given-names>Petter</given-names></name><xref ref-type="aff" rid="af1-ehp-117-1373">1</xref><xref ref-type="aff" rid="af2-ehp-117-1373">2</xref><xref ref-type="corresp" rid="c1-ehp-117-1373"/></contrib><contrib contrib-type="author"><name><surname>Bellander</surname><given-names>Tom</given-names></name><xref ref-type="aff" rid="af2-ehp-117-1373">2</xref></contrib><contrib contrib-type="author"><name><surname>Schneider</surname><given-names>Alexandra</given-names></name><xref ref-type="aff" rid="af3-ehp-117-1373">3</xref></contrib><contrib contrib-type="author"><name><surname>Breitner</surname><given-names>Susanne</given-names></name><xref ref-type="aff" rid="af3-ehp-117-1373">3</xref></contrib><contrib contrib-type="author"><name><surname>Forastiere</surname><given-names>Francesco</given-names></name><xref ref-type="aff" rid="af4-ehp-117-1373">4</xref></contrib><contrib contrib-type="author"><name><surname>Hampel</surname><given-names>Regina</given-names></name><xref ref-type="aff" rid="af3-ehp-117-1373">3</xref></contrib><contrib contrib-type="author"><name><surname>Illig</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="af3-ehp-117-1373">3</xref></contrib><contrib contrib-type="author"><name><surname>Jacquemin</surname><given-names>B&#x000e9;n&#x000e9;dicte</given-names></name><xref ref-type="aff" rid="af5-ehp-117-1373">5</xref><xref ref-type="aff" rid="af6-ehp-117-1373">6</xref></contrib><contrib contrib-type="author"><name><surname>Katsouyanni</surname><given-names>Klea</given-names></name><xref ref-type="aff" rid="af7-ehp-117-1373">7</xref></contrib><contrib contrib-type="author"><name><surname>von Klot</surname><given-names>Stephanie</given-names></name><xref ref-type="aff" rid="af3-ehp-117-1373">3</xref><xref ref-type="aff" rid="af8-ehp-117-1373">8</xref></contrib><contrib contrib-type="author"><name><surname>Koenig</surname><given-names>Wolfgang</given-names></name><xref ref-type="aff" rid="af9-ehp-117-1373">9</xref></contrib><contrib contrib-type="author"><name><surname>Lanki</surname><given-names>Timo</given-names></name><xref ref-type="aff" rid="af10-ehp-117-1373">10</xref></contrib><contrib contrib-type="author"><name><surname>Nyberg</surname><given-names>Fredrik</given-names></name><xref ref-type="aff" rid="af2-ehp-117-1373">2</xref><xref ref-type="aff" rid="af11-ehp-117-1373">11</xref></contrib><contrib contrib-type="author"><name><surname>Pekkanen</surname><given-names>Juha</given-names></name><xref ref-type="aff" rid="af10-ehp-117-1373">10</xref></contrib><contrib contrib-type="author"><name><surname>Pistelli</surname><given-names>Riccardo</given-names></name><xref ref-type="aff" rid="af12-ehp-117-1373">12</xref></contrib><contrib contrib-type="author"><name><surname>Pitsavos</surname><given-names>Christos</given-names></name><xref ref-type="aff" rid="af13-ehp-117-1373">13</xref></contrib><contrib contrib-type="author"><name><surname>Rosenqvist</surname><given-names>M&#x000e5;rten</given-names></name><xref ref-type="aff" rid="af1-ehp-117-1373">1</xref></contrib><contrib contrib-type="author"><name><surname>Sunyer</surname><given-names>Jordi</given-names></name><xref ref-type="aff" rid="af5-ehp-117-1373">5</xref><xref ref-type="aff" rid="af14-ehp-117-1373">14</xref><xref ref-type="aff" rid="af15-ehp-117-1373">15</xref><xref ref-type="aff" rid="af16-ehp-117-1373">16</xref></contrib><contrib contrib-type="author"><name><surname>Peters</surname><given-names>Annette</given-names></name><xref ref-type="aff" rid="af3-ehp-117-1373">3</xref></contrib></contrib-group><aff id="af1-ehp-117-1373"><label>1</label> Department of Cardiology, Karolinska Institutet, Stockholm South Hospital, Stockholm, Sweden</aff><aff id="af2-ehp-117-1373"><label>2</label> Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden</aff><aff id="af3-ehp-117-1373"><label>3</label> Helmholtz Zentrum M&#x000fc;nchen, German Research Center for Environmental Health, Institute of Epidemiology, Munich, Germany</aff><aff id="af4-ehp-117-1373"><label>4</label> Department of Epidemiology, Local Health Authority, RME, Rome, Italy</aff><aff id="af5-ehp-117-1373"><label>5</label> Centre for Research in Environmental Epidemiology, Barcelona, Spain</aff><aff id="af6-ehp-117-1373"><label>6</label> Institut national de la sant&#x000e9; et de la recherche m&#x000e9;dicale U780, Epidemiology and Biostatistics, University Paris-Sud, IFR69, Villejuif, France</aff><aff id="af7-ehp-117-1373"><label>7</label> Department of Hygiene and Epidemiology, University of Athens Medical School, Athens, Greece</aff><aff id="af8-ehp-117-1373"><label>8</label> Department of Environmental Health, Harvard School of Public Health, Boston, Massachusetts, USA</aff><aff id="af9-ehp-117-1373"><label>9</label> Department of Internal Medicine II&#x02014;Cardiology, University of Ulm Medical Center, Ulm, Germany</aff><aff id="af10-ehp-117-1373"><label>10</label> Environmental Epidemiology Unit, National Public Health Institute, Kuopio, Finland</aff><aff id="af11-ehp-117-1373"><label>11</label> AstraZeneca R&#x00026;D, M&#x000f6;lndal, Sweden</aff><aff id="af12-ehp-117-1373"><label>12</label> Department of Pneumology, Catholic University, Rome, Italy</aff><aff id="af13-ehp-117-1373"><label>13</label> First Cardiology Clinic, Ippokration Hospital, University of Athens, Athens, Greece</aff><aff id="af14-ehp-117-1373"><label>14</label> Municipal Institute of Medical Research, Barcelona, Spain</aff><aff id="af15-ehp-117-1373"><label>15</label> CIBER in Epidemiology and Public Health, Barcelona, Spain</aff><aff id="af16-ehp-117-1373"><label>16</label> Department of Health and Experimental Sciences, University Pompeu Fabra, Barcelona, Spain</aff><author-notes><corresp id="c1-ehp-117-1373">Address correspondence to P. Ljungman, Unit of Environmental Health, Institute of Environmental Medicine, Karolinska Institutet, Norrbacka plan 3, SE-171 76, Stockholm, Sweden. Telephone: 46-73-205-53-30. Fax: 46-8-737-37-70. E-mail: <email>petter.ljungman@ki.se</email></corresp><fn><p>F.N. is employed by AstraZeneca, and AstraZeneca also supports his academic part-time adjunct position as Lecturer in Molecular Epidemiology at Karolinska Institutet. AstraZeneca did not contribute any direct financing to this study. The remaining authors declare they have no competing financial interests.</p></fn></author-notes><pub-date pub-type="ppub"><month>9</month><year>2009</year></pub-date><pub-date pub-type="epub"><day>6</day><month>4</month><year>2009</year></pub-date><volume>117</volume><issue>9</issue><fpage>1373</fpage><lpage>1379</lpage><history><date date-type="received"><day>5</day><month>11</month><year>2008</year></date><date date-type="accepted"><day>6</day><month>4</month><year>2009</year></date></history><permissions><copyright-statement>This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original DOI.</copyright-statement></permissions><abstract><sec><title>Background</title><p>Evidence suggests that cardiovascular effects of air pollution are mediated by inflammation and that air pollution can induce genetic expression of the interleukin-6 gene (<italic>IL6</italic>).</p></sec><sec><title>Objectives</title><p>We investigated whether <italic>IL6</italic> and fibrinogen gene variants can affect plasma IL-6 responses to air pollution in patients with cardiovascular disease.</p></sec><sec><title>Methods</title><p>We repeatedly determined plasma IL-6 in 955 myocardial infarction survivors from six European cities (<italic>n</italic> = 5,539). We conducted city-specific analyses using additive mixed models adjusting for patient characteristics, time trend, and weather to assess the impact of air pollutants on plasma IL-6. We pooled city-specific estimates using meta-analysis methodology. We selected three <italic>IL6</italic> single-nucleotide polymorphisms (SNPs) and one SNP each from the fibrinogen &#x003b1;-chain gene (<italic>FGA</italic>) and &#x003b2;-chain gene (<italic>FGB</italic>) for gene&#x02013;environment analyses.</p></sec><sec><title>Results</title><p>We found the most consistent modifications for variants in <italic>IL6</italic> rs2069832 and <italic>FBG</italic> rs1800790 after exposure to carbon monoxide (CO; 24-hr average; <italic>p</italic>-values for interaction, 0.034 and 0.019, respectively). Nitrogen dioxide effects were consistently modified, but <italic>p</italic>-values for interaction were larger (0.09 and 0.19, respectively). The strongest effects were seen 6&#x02013;11 hr after exposure, when, for example, the overall effect of a 2.2% increase in IL-6 per 0.64 mg/m<sup>3</sup> CO was modified to a 10% (95% confidence interval, 4.6&#x02013;16%) increase in IL-6 (<italic>p</italic>-value for interaction = 0.002) for minor homozygotes of <italic>FGB</italic> rs1800790.</p></sec><sec><title>Conclusions</title><p>The effect of gaseous traffic-related air pollution on inflammation may be stronger in genetic subpopulations with ischemic heart disease. This information could offer an opportunity to identify postinfarction patients who would benefit more than others from a cleaner environment and antiinflammatory treatment.</p></sec></abstract><kwd-group><kwd>air pollution</kwd><kwd>fibrinogen</kwd><kwd>gene-environment interaction</kwd><kwd>interleukin-6</kwd><kwd>myocardial infarction survivors</kwd><kwd>polymorphisms</kwd></kwd-group></article-meta></front><body><p>Although air pollution has been recognized as a risk factor for cardiovascular morbidity and mortality (<xref ref-type="bibr" rid="b3-ehp-117-1373">Brook et al. 2004</xref>), its mechanism of action remains largely unclear. Inflammation has been proposed as a possible mechanism, and this possibility is supported by experimental models (<xref ref-type="bibr" rid="b8-ehp-117-1373">Donaldson et al. 2003</xref>; <xref ref-type="bibr" rid="b19-ehp-117-1373">Niwa et al. 2008</xref>; <xref ref-type="bibr" rid="b36-ehp-117-1373">Vogel et al. 2005</xref>) and population studies (<xref ref-type="bibr" rid="b29-ehp-117-1373">R&#x000fc;ckerl et al. 2006</xref>, <xref ref-type="bibr" rid="b28-ehp-117-1373">2007</xref>; <xref ref-type="bibr" rid="b31-ehp-117-1373">Schwartz 2001</xref>). A key player in modulating the inflammatory response is interleukin-6 (IL-6), a pleiotropic cytokine shown to be associated with increased risk of cardiovascular morbidity and mortality (<xref ref-type="bibr" rid="b24-ehp-117-1373">Rattazzi et al. 2003</xref>).</p><p>Levels of IL-6 in plasma may be affected by specific genetic variations of both the gene encoding IL-6 (<italic>IL6</italic>; GenBank accession number M18403) (<xref ref-type="bibr" rid="b2-ehp-117-1373">Bennermo et al. 2004</xref>; <xref ref-type="bibr" rid="b4-ehp-117-1373">Burzotta et al. 2001</xref>) and genes encoding the fibrinogen protein [&#x003b1;-chain (<italic>FGA</italic>), &#x003b2;-chain (<italic>FGB</italic>), and &#x003b3;-chain (<italic>FGG</italic>); GenBank accession numbers NM_000508, NM_005141, and NM_021870, respectively] (<xref ref-type="bibr" rid="b14-ehp-117-1373">Mannila et al. 2007</xref>; <xref ref-type="bibr" rid="b18-ehp-117-1373">National Center for Biotechnology Information 2009</xref>). Because IL-6 principally stimulates fibrinogen production (<xref ref-type="bibr" rid="b7-ehp-117-1373">Dalmon et al. 1993</xref>), a possible explanation for increased IL-6 levels in association with certain fibrinogen gene polymorphisms is a positive feedback mechanism where fibrinogen products (fibrin) increase IL-6 production in monocytes and macrophages (<xref ref-type="bibr" rid="b25-ehp-117-1373">Ritchie et al. 1982</xref>; <xref ref-type="bibr" rid="b26-ehp-117-1373">Robson et al. 1994</xref>; <xref ref-type="bibr" rid="b34-ehp-117-1373">Szaba and Smiley 2002</xref>).</p><p>Several studies have shown expression of the <italic>IL6</italic> gene to be induced by air pollution (<xref ref-type="bibr" rid="b23-ehp-117-1373">Quay et al. 1998</xref>; <xref ref-type="bibr" rid="b36-ehp-117-1373">Vogel et al. 2005</xref>; <xref ref-type="bibr" rid="b37-ehp-117-1373">Watterson et al. 2007</xref>), but no studies have examined induction of fibrinogen genes or examined variants of the <italic>IL6</italic> gene and how they may possibly lead to differences in individual susceptibility to air pollution. In previous analyses from this study population, genetic polymorphisms of fibrinogen have been associated with increased fibrinogen plasma levels (<xref ref-type="bibr" rid="b9-ehp-117-1373">Jacquemin et al. 2008</xref>) and modified the fibrinogen response to ambient particulate matter (PM) (<xref ref-type="bibr" rid="b21-ehp-117-1373">Peters et al. 2009</xref>). In light of a positive feedback mechanism of fibrinogen levels on IL-6 levels, polymorphisms of fibrinogen may potentially affect IL-6 levels differently through differences in transcription rate of fibrinogen. Indeed, combinations of polymorphisms in the <italic>IL6</italic> and fibrinogen genes may interact to further increase IL-6 levels.</p><p>Myocardial infarction (MI) survivors have a compromised long-term prognosis, making relative risk reduction particularly advantageous. We hypothesized that the moderate effect of air pollution seen on inflammatory markers in previous studies is stronger in MI survivors with specific variants of inflammatory genes such as <italic>IL6</italic> and the fibrinogen genes. We aimed to assess the influence of polymorphisms of the <italic>IL6</italic>, <italic>FGA</italic>, and <italic>FGB</italic> genes on the IL-6 response to air pollution and to explore the influence of gene&#x02013;gene interactions on this effect.</p><p>We present here results of a meta-analysis of six independent studies whose data were collected by a common protocol and that were designed to look at gene&#x02013;air pollution interactions (<xref ref-type="bibr" rid="b22-ehp-117-1373">Peters et al. 2007</xref>)</p><sec sec-type="materials|methods"><title>Materials and Methods</title><sec sec-type="subjects"><title>Patients</title><p>IL-6 concentrations were assessed in the AIRGENE study, a multicenter longitudinal study of MI survivors from six European cities: Athens, Greece; Augsburg, Germany; Barcelona, Spain; Helsinki, Finland; Rome, Italy; Stockholm, Sweden (<xref ref-type="bibr" rid="b22-ehp-117-1373">Peters et al. 2007</xref>). Subjects between 35 and 80 years of age who had experienced an MI between 4 months and 6 years before start of the study were recruited through population-based MI registries (KORA MI Registry Augsburg, and registries in Barcelona and Stockholm) or from administrative databases of hospital admissions (Athens, Helsinki, and Rome). Patients with MI or interventional procedures &#x0003c; 3 months before the beginning of the study or with chronic recurring inflammatory diseases such as Crohn&#x02019;s disease were excluded. MI was defined based on the European Society of Cardiology/American College of Cardiology Committee criteria (<xref ref-type="bibr" rid="b1-ehp-117-1373">Anonymous 2000</xref>). Study protocols were approved by local ethics committees, and written consent was obtained from all patients before inclusion in the study.</p><p>Patients were invited to participate in six to eight clinical visits between May 2003 and July 2004. The visits were scheduled every 4&#x02013;6 weeks, on the same weekday and at the same time of the day to minimize the impact of weekly and circadian variation in biological processes and air pollution levels. The average number of visits per patient was 5.8, resulting in 5,813 plasma samples. The subjects recruited were predominantly middle-age men who had survived one MI for &#x0003e; 2 years on average (<xref ref-type="table" rid="t1-ehp-117-1373">Table 1</xref>).</p></sec><sec sec-type="methods"><title>Field study</title><p>The fieldwork was based on standard operating procedures developed by the AIRGENE study group. At a baseline clinical visit, a single blood sample for DNA analysis was collected and stored at &#x02212; 80&#x000b0;C until shipment on dry ice for DNA isolation at the laboratory at the Helmholtz Zentrum M&#x000fc;nchen&#x02014;German Research Center for Environmental Health in Neuherberg, Germany. Patients were also characterized at baseline with respect to comorbidities, smoking history, environmental tobacco exposures, socioeconomic status, regular exercise, and alcohol and medication intake. Measurements of blood pressure, body mass index (BMI), total cholesterol, high-density lipoprotein (HDL) cholesterol, glycosylated hemoglobin A1c (HbA1c), and N-terminal proB-type natriuretic peptide (NT-proBNP) were performed.</p><p>At each repeated clinical visit, including baseline, a short questionnaire was administered regarding smoking behavior, time of last meal, and a 7-day recall of medication intake. In addition, a blood sample was collected for IL-6 assessment according to previously described procedures (<xref ref-type="bibr" rid="b22-ehp-117-1373">Peters et al. 2007</xref>). For quality assurance purposes, 102 randomly selected IL-6 duplicate samples from all centers except Athens were analyzed, showing an average coefficient of variation of 13.8% (from 3.2% in Augsburg to 23.4% in Stockholm).</p></sec><sec><title>Air pollution</title><p>Data on hourly means of carbon monoxide (CO), nitrogen dioxide (NO<sub>2</sub>), PM with an aerodynamic diameter &#x02264; 10 &#x003bc;m (PM<sub>10</sub>) or &#x02264; 2.5 &#x003bc;m (PM<sub>2.5</sub>), particle number concentration (PNC), air temperature, and relative humidity were collected for each city (<xref ref-type="bibr" rid="b28-ehp-117-1373">R&#x000fc;ckerl et al. 2007</xref>) and aggregated to 6- and 24-hr running means on the basis of standard procedures (<xref ref-type="bibr" rid="b10-ehp-117-1373">Katsouyanni et al. 1995</xref>). Inhalable (PM<sub>10</sub>) and thoracic (PM<sub>2.5</sub>) particles were strongly correlated (overall <italic>r</italic> across cities for consecutive 24-hr means = 0.81), and local combustion-related pollutants were strongly correlated (CO and NO<sub>2</sub>, overall <italic>r</italic> = 0.68; and both also to PNC, overall <italic>r</italic> = 0.67 and 0.74, respectively). We also saw this overall pattern in the single cities, with the exception of Athens and Stockholm, which showed less correlation between CO and PNC.</p></sec><sec><title>Genotyping</title><p>We extracted DNA from EDTA (ethylenediaminetetraacetic acid)&#x02013;anticoagulated blood using a salting out procedure. We selected 10 single-nucleotide polymorphisms (SNPs) for <italic>IL6</italic> and 21 SNPs for <italic>FGA</italic>, <italic>FGB</italic>, and <italic>FGG</italic> and genotyped them as described previously (<xref ref-type="bibr" rid="b22-ehp-117-1373">Peters et al. 2007</xref>). Genotyping success rates ranged between 97.9% for <italic>IL6</italic> rs2069832 and 99.8% for <italic>FGB</italic> rs1800790.</p></sec><sec><title>SNP selection</title><p>We selected IL6 SNPs that showed an association with IL-6 levels in our sample (<italic>p</italic>-value &#x0003c; 0.05) and were in Hardy-Weinberg equilibrium for gene&#x02013;environment analyses (Ljungman et al. 2008). Five SNPs met this criterion, but <italic>IL6</italic> rs2069832 and rs1800795 were in very high linkage disequilibrium (LD) (<italic>r</italic><sup>2</sup> = 0.99), as were rs1554606 and rs2069845 (<italic>r</italic><sup>2</sup> = 0.99). Therefore, one of each pair (rs2069832 and rs1554606) was chosen for further gene&#x02013;environment interaction analyses. <italic>IL6</italic> rs2069840 was, however, in weak LD (<italic>r</italic><sup>2</sup> = 0.31 to 0.35) with the other selected SNPs and might have independent effects. Associations have been seen between IL-6 levels and fibrinogen levels (<xref ref-type="bibr" rid="b15-ehp-117-1373">Mannila et al. 2004</xref>), and previous analyses in our study population (<xref ref-type="bibr" rid="b9-ehp-117-1373">Jacquemin et al. 2008</xref>) have shown evidence of modification of the effect of fibrinogen polymorphisms on fibrinogen levels by levels of IL-6. Consequently, we selected one SNP each from the genes coding the &#x003b1;-chain (<italic>FGA</italic>, rs2070011) and &#x003b2;-chain (<italic>FGB</italic>, rs1800790) of fibrinogen, which were both associated with fibrinogen levels in the previous study (<xref ref-type="bibr" rid="b9-ehp-117-1373">Jacquemin et al. 2008</xref>), based on these results.</p><p>Of the 1003 study participants, we restricted all further analyses to 955 (95%) for whom complete information on the five SNPs was available.</p></sec><sec sec-type="methods"><title>Statistical analysis</title><p>We estimated the effect of the SNPs on IL-6 using linear mixed effects models with random subject-specific intercepts, adjusting linearly for the variables age, BMI, pack-years of cigarette smoking, HDL cholesterol, systolic blood pressure, alcohol intake, and logarithm of NT-proBNP and for the categorical variables city, HbA1c, number of earlier MIs, history of heart failure or diabetes, and symptoms of phlegm. SNP genotypes were coded as an ordinal variable by the number of copies of the minor allele (0, 1, 2; denoted 1 1, 1 2, and 2 2 in tables and figures) as described in Ljungman et al. (2008).</p><p>For detailed information on model selection procedures, see <xref ref-type="bibr" rid="b28-ehp-117-1373">R&#x000fc;ckerl et al. (2007)</xref>. We estimated the overall effects of air pollutants on IL-6 in city-specific additive mixed models [see Supplemental Material, Table 1 (doi: 10.1289/ehp.0800370.S1 via <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/">http://dx.doi.org/</ext-link>)], adjusting for the above-described patient characteristics, time trend, and the weather parameters air temperature and relative humidity to accommodate the different characteristics and meteorologic conditions across Europe, as previously reported (<xref ref-type="bibr" rid="b28-ehp-117-1373">R&#x000fc;ckerl et al. 2007</xref>). We tested the robustness of the model to exclusion of all time-invariant variables in sensitivity analyses.</p><p>Gene&#x02013;environment interactions were estimated for each SNP by including in these models the main effect of the SNP (additive genetic model), the main effect of the air pollution effect, and the interaction term between air pollution and SNP. We determined the <italic>a priori</italic> exposure window for all gene&#x02013;environment interaction analyses to be the average exposure during the 24 hr immediately preceding blood withdrawal based on results from previous analyses (<xref ref-type="bibr" rid="b28-ehp-117-1373">R&#x000fc;ckerl et al. 2007</xref>) and the short half-life of IL-6. Secondary analyses were performed for other time windows of exposure as well as for gene&#x02013;gene combinations of polymorphisms showing effect modification. We explored consistency of patterns of association in city-specific analyses. In assessing the contributions of the different exposure windows to the interaction effect, we also performed analyses for the subjects carrying at least one risk allele using distributed lags, thus allowing for independence of effects for each time window of exposure in a common model.</p><p>Effect estimates by genotypes are presented together with 95% confidence intervals (CIs). Because the study of gene&#x02013;environment interactions was of an exploratory nature, we did not attempt to correct for multiple comparisons for these analyses. Estimates are presented for an increase of the pollutants by a one interquartile increase in pollutant exposure range and expressed as a relative change of the overall geometric mean in IL-6. We tested the assumption of an additive genetic effect by using an indicator variable for the heterozygote genotype in the model. For overall results, we pooled city-specific estimates using meta-analysis methodology (<xref ref-type="bibr" rid="b35-ehp-117-1373">van Houwelingen et al. 2002</xref>). Heterogeneity of effect estimates was assessed with a chi-square test with 5 degrees of freedom. If the <italic>p</italic>-value was &#x0003c; 0.1, random effect models were applied for combining effect estimates.</p></sec></sec><sec sec-type="results"><title>Results</title><p>Mean IL-6 ranged from 2.5 pg/mL in Augsburg to 3.5 pg/mL in Barcelona (<xref ref-type="table" rid="t1-ehp-117-1373">Table 1</xref>). The consecutive 24-hr mean levels of CO ranged from 0.29 mg/m<sup>3</sup> in Stockholm to 1.48 mg/m<sup>3</sup> in Athens. The within-interquartile difference ranged from 0.08 in Helsinki to 0.73 in Athens.</p><p>Less than 5% of the subjects were homozygotes for the minor allele of <italic>FGB</italic> rs1800790, whereas 9&#x02013;19% of subjects were homozygotes for minor allele of the <italic>IL6</italic> and <italic>FGA</italic> polymorphisms (<xref ref-type="table" rid="t2-ehp-117-1373">Table 2</xref>). Genotype frequencies differed among the cities for all SNPs (chi-square test, <italic>p</italic> &#x0003c; 0.03), displaying a north&#x02013;south gradient, with the minor alleles of <italic>IL6</italic> rs2069832 and <italic>IL6</italic> rs2069845 having higher frequencies in the northern cities and the minor alleles of <italic>IL6</italic> rs2069840 having higher frequencies in the southern cities. The fibrinogen SNPs did not show such a pattern (data not shown).</p><sec><title>Overall effect of genotype on IL-6 levels</title><p><xref ref-type="table" rid="t2-ehp-117-1373">Table 2</xref> shows the associations of SNPs with an increased plasma level of IL-6 in this data set. The minor alleles of <italic>IL6</italic> rs2069832 and <italic>IL6</italic> rs2069845 and the major allele of <italic>IL6</italic> rs2069840 were significantly associated with an increased plasma level (at <italic>p</italic> &#x0003c; 0.05) (Ljungman et al. 2008). The minor allele of <italic>FGA</italic> rs2070011 showed nonsignificant association to increased plasma levels of IL-6, whereas <italic>FGB</italic> rs1800790 polymorphism showed no clear association to plasma IL-6. We found no evidence of deviation from the additive model for these SNPs (<italic>p</italic>-value for heterozygote indicator variable &#x0003e; 0.05).</p></sec><sec><title>Overall effects of air pollution on IL-6 levels</title><p>Elevated concentrations of CO averaged during the 0&#x02013;24 hr preceding blood sampling were not significantly associated with increased plasma IL-6 levels (<xref ref-type="table" rid="t3-ehp-117-1373">Table 3</xref>), but elevated concentrations during 6&#x02013;11 hr intervals preceding sampling were associated (2.2% change of overall mean IL-6; 95% CI, 0.3&#x02013;4.2%). For other pollutants, NO<sub>2</sub> levels averaged over the 0&#x02013;24 hr preceding blood sampling showed associations with an increase in plasma IL-6 (<xref ref-type="table" rid="t3-ehp-117-1373">Table 3</xref>), and PNC levels showed significant associations for both 6&#x02013;11 hr and 12&#x02013;17 hr exposure windows preceding sampling [1.8% change (95% CI, 0.2&#x02013;3.5%) and 2.6% change (95% CI, 0.8&#x02013;4.5%), respectively].</p></sec><sec><title>Genotype modification of IL-6 response (24-hr exposure windows)</title><p>Subjects with the homozygous major allele genotypes for all three <italic>IL6</italic> polymorphisms showed larger IL-6 responses to increased CO, but only for for <italic>IL6</italic> rs2069832 was a similar genetic inter-action seen with increased NO<sub>2</sub> (<xref ref-type="table" rid="t4-ehp-117-1373">Table 4</xref>).</p><p>Subjects with the homozygote minor allele genotype of <italic>FGB</italic> rs1800790 showed both a larger and clearer effect modification for the IL-6 response to increased CO compared with the <italic>IL6</italic> SNPs. The overall effect of a 0.8% increase in IL-6 per 0.34 mg/m<sup>3</sup> increase of CO in the preceding 0&#x02013;24 hr seemed to be confined to individuals carrying the minor allele of <italic>FGB</italic> rs1800790. In the 4% of the study sample that were homozygous with this allele, the corresponding CO effect on IL-6 was a 4.5% increase. We saw similar magnitudes of effect modification for NO<sub>2</sub>, but the effect modification pattern was not statistically significant. The <italic>FGA</italic> SNP did not modify the response to air pollution. These results were robust to sensitivity analysis excluding all time-invariant variables from the final model and only maintaining time trend and meteorology (data not shown).</p><p>For PM pollutants, we found a similar pattern of effect modification of <italic>FGB</italic> rs1800790 for increased levels of PM<sub>2.5</sub> and PM<sub>10</sub> during the preceding 0&#x02013;24 hr, but with less precision of effect for PM<sub>10</sub> (<xref ref-type="fig" rid="f1-ehp-117-1373">Figure 1</xref>). For ultrafine particles measured by PNC and for <italic>IL6</italic> rs2069832, the pattern was less clear.</p><p>When we classified different combinations of the <italic>IL6</italic> rs2069832 and <italic>FGB</italic> rs1800790 genotypes according to number of risk alleles into low, intermediate, and high risk (<xref ref-type="fig" rid="f2-ehp-117-1373">Figure 2A</xref>), we found significant modification of the IL-6 response to an increase in the preceding 0&#x02013;24 hr average of CO as well as both NO<sub>2</sub> and PM<sub>2.5</sub> (<xref ref-type="fig" rid="f2-ehp-117-1373">Figure 2B</xref>). Subjects with &#x02265; three high-risk alleles from both SNPs (154 subjects) had the largest IL-6 response.</p></sec><sec><title>Genotype modification of IL-6 response (6-hr exposure windows)</title><p>Analyses of 6-hr exposure windows during the 24 hr immediately preceding blood sampling showed the clearest effect modification of the IL-6 response to CO within the three preceding 6-hr windows (<xref ref-type="fig" rid="f3-ehp-117-1373">Figure 3</xref>). We found greatest effect modification for <italic>FGB</italic> rs1800790 for increased CO during the 6&#x02013;11 hr preceding sampling. The overall effect of a 2.2% increase in IL-6 per 0.64 mg/m<sup>3</sup> increase of CO in this time window seemed again to be confined to individuals carrying the minor allele of <italic>FGB</italic> rs1800790, with a 10% (95% CI, 4.6&#x02013;16%) increase in homozygotes (4% of study sample). In homozygotes for the major allele of IL6 rs2069832 (36% of the study sample), the corresponding increase was 3.6% (95% CI, 1.0&#x02013;6.2%). Differences in the NO<sub>2</sub> (<xref ref-type="fig" rid="f3-ehp-117-1373">Figure 3</xref>) and PM<sub>2.5</sub> (data not shown) effects across genetic subgroups for different 6-hr exposure windows were similar but weaker. The distributed lag analyses restricted to subjects with at least one minor allele of <italic>FGB</italic> rs1800790 (GA or AA, 37% of study sample) or one major allele of <italic>IL6</italic> 2069832 (GA or AA, 83% of study sample) for 6-hr and 24-hr time windows showed associations with increased IL-6 for increases in CO for the 0&#x02013;5 hr and 6&#x02013;11 hr preceding sampling [see Supplemental Material, Figure 1 (doi: 10.1289/ehp.0800370.S1)]. The IL-6 increase seen in minor allele holders of <italic>FGB</italic> rs1800790 for 0&#x02013;23 hr exposure of CO seemed to be mainly driven by exposure in the 6&#x02013;11 hr time window. We found a similar but weaker pattern for 0&#x02013;23 hr exposure in major allele holders of <italic>IL6</italic> rs2069832.</p></sec><sec><title>City-specific modification of IL-6 response to CO and NO<sub>2</sub></title><p>In a comparison of city-specific analyses for <italic>IL6</italic> rs2069832 [see Supplemental Material, Figure 2 (doi: 10.1289/ehp.0800370. S1)], modification of the IL-6 response to preceding 0&#x02013;24 hr average of increased CO and NO<sub>2</sub> showed consistency between the pollutants, with the clearest effect modification seen in Helsinki, Barcelona, and Athens. For <italic>FGB</italic> rs1800790 [see Supplemental Material, Figure 3 (doi: 10.1289/ehp.0800370.S1)], we found the strongest effect modification in Athens and Augsburg, and the effects were consistent for both pollutants except in Stockholm. Although we found variation across cities because of reduced power in the city-specific analyses, we found no significant heterogeneity of city- specific effects (<italic>p</italic>-value &#x0003e; 0.1).</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>We found evidence of gene&#x02013;environment interaction where the SNPs <italic>IL6</italic> rs2069832 and <italic>FGB</italic> rs1800790 modified the effects of air pollution on IL-6 levels in MI survivors. All pollutants showed similar patterns of effect, but results were most apparent for CO. The influence of CO on IL-6 levels was strongest in subjects with the major allele of <italic>IL6</italic> rs2069832 and the minor allele of <italic>FGB</italic> rs1800790, and the combination of these two genetic variants, present in 16% of subjects, resulted in a significant gene&#x02013;gene&#x02013;environment interaction, potentially indicating a higher risk for health effects from air pollution in these patients with ischemic heart disease. We found similar magnitudes of effect modification with respect to air pollution for <italic>IL6</italic> rs2069840 and <italic>IL6</italic> rs2069845, but we found no effect modification for <italic>FGA</italic> rs2070011.</p><p>We found small effects of air pollution on IL-6 levels in the overall population. The groups defined by the minor allele of <italic>FGB</italic> rs1800790, and to a lesser extent by the major allele of <italic>IL6</italic> rs2069832, seem to be the driving force between the associations seen, suggesting a restriction of the effect of air pollution to groups of MI survivors of specific genotypes.</p><p>NO<sub>2</sub> was the pollutant with the most convincing effects on IL-6 levels with respect to the a priori specified time window of exposure (0&#x02013;24 hr) when considering the overall population, regardless of genotype. Modification of air pollution effects by SNPs was, however, clearest for CO, although the other pollutants in general followed a similar pattern. CO has been proposed as a probable culprit to cardiovascular effects of air pollution (<xref ref-type="bibr" rid="b6-ehp-117-1373">Dales 2004</xref>; <xref ref-type="bibr" rid="b16-ehp-117-1373">McGrath 2000</xref>) in addition to PM. In this study we did not have sufficient power to more specifically identify the most important air pollution component or source, and we acknowledge that we studied a mixture of correlated pollutants. Ambient CO levels measured using fixed monitors have been shown to correlate better to personal exposure to PM rather than to personal exposure to CO (<xref ref-type="bibr" rid="b30-ehp-117-1373">Sarnat et al. 2005</xref>; <xref ref-type="bibr" rid="b33-ehp-117-1373">Schwartz et al. 2007</xref>), so although sensitivity analyses adjusting for the level of PM<sub>2.5</sub> in the models showed support for an independent effect of CO (data not shown), we can not be sure of a specific CO effect. Secondary analyses showed that the interaction effect was clearest and strongest during the first 24 hr and particularly 6&#x02013;11 hr preceding blood withdrawal, consistent with the short half-life of IL-6. The early effect was further supported by the distributed lag analyses of the subjects carrying the risk allele for <italic>IL6</italic> rs2069832 and <italic>FGB</italic> rs1800790. Given the strong correlation of 6-hr exposure windows, it is probable that effects seen for exposure window 12&#x02013;17 hr and possibly also 0&#x02013;5 hr reflect this correlation rather than independent effects of these exposure windows.</p><p>Although <italic>FGB</italic> rs1800790 displayed an interaction effect with CO on IL-6 levels, we found no effect of the polymorphism on IL-6 in these patients when not taking air pollution into account. A previous study of the same population (<xref ref-type="bibr" rid="b9-ehp-117-1373">Jacquemin et al. 2008</xref>) investigating the effect of fibrinogen polymorphisms on fibrinogen plasma levels found no interaction effect with high levels of IL-6 on fibrinogen levels for this polymorphism, in contrast to <italic>FGA</italic> rs2070011. However, a follow-up study (<xref ref-type="bibr" rid="b21-ehp-117-1373">Peters et al. 2009</xref>) showed that <italic>FGB</italic> rs1800790 modified the effect of a 5-day average exposure to ambient PM on circulating fibrinogen levels. The production of fibrinogen is stimulated by IL-6, but there is also evidence both <italic>in vivo</italic> (<xref ref-type="bibr" rid="b34-ehp-117-1373">Szaba and Smiley 2002</xref>) and <italic>in vitro</italic> (<xref ref-type="bibr" rid="b26-ehp-117-1373">Robson et al. 1994</xref>) suggesting a positive feedback mechanism whereby fibrinogen products in turn stimulate IL-6 production and release from monocytes. Although this might suggest that the increased IL-6 levels seen in MI survivors with a minor allelic genotype of <italic>FGB</italic> rs1800790 are mediated via increased fibrinogen levels, the effects on IL-6 levels occurred within 12 hr rather than after 5 days.</p><p>In this study, subjects with major alleles of <italic>IL6</italic> rs2069832 and rs2069845 had lower IL-6 concentrations than did those with minor alleles, but they seemed to react more strongly to CO exposure than did minor allele holders. The reason for this pattern is unclear. Our previous study (Ljungman et al. 2008) revealed a tendency of a greater within-individual variability for major allele holders compared with minor allele holders. Taken together, this may indicate that major allele holders are more likely to respond with inflammation to stimuli such as air pollution but from a lower basal level of IL-6.</p><p>Air pollution has been associated in epidemiologic studies with the onset of MIs in both previously healthy subjects and cardiac patients (<xref ref-type="bibr" rid="b20-ehp-117-1373">Peters et al. 2001</xref>; <xref ref-type="bibr" rid="b38-ehp-117-1373">Zanobetti and Schwartz 2005</xref>). In addition, human experimental (<xref ref-type="bibr" rid="b17-ehp-117-1373">Mills et al. 2007</xref>) and epidemiologic (<xref ref-type="bibr" rid="b5-ehp-117-1373">Chuang et al. 2008</xref>) studies have demonstrated an effect of air pollution on ST-segment changes in electrocardiograms indicating the triggering of acute ischemia. The gene&#x02013;environment interaction observed for these two SNPs in our study emphasizes that certain genetic subgroups of cardiac patients may react more strongly toward air pollution than do others. Similar genetic interaction with air pollutants has been seen in human and animal models for lung disease (<xref ref-type="bibr" rid="b11-ehp-117-1373">Kleeberger 2003</xref>; <xref ref-type="bibr" rid="b13-ehp-117-1373">London 2007</xref>) and oxidative stress (<xref ref-type="bibr" rid="b27-ehp-117-1373">Romieu et al. 2006</xref>; <xref ref-type="bibr" rid="b32-ehp-117-1373">Schwartz et al. 2005</xref>). Although both the <italic>IL6</italic> and <italic>FGB</italic> genes are probable candidates affecting the levels of the known cardiovascular biomarker IL-6, the actual polymorphisms responsible for the observed effect modification may be other strongly correlated SNPs or combinations of SNPs. Indeed, in our population, <italic>IL6</italic> rs2069832 has very high LD with <italic>IL6</italic> rs1800795, a functional SNP located in the promoter region. The reason for focusing on <italic>IL6</italic> rs2069832 instead of <italic>IL6</italic> rs1800795 was that the overall pooled effects of <italic>IL6</italic> rs1800795 on IL-6 levels showed slightly more heterogeneity across cities (Ljungman et al. 2008). To confirm the effects of the studied polymorphisms, functional analyses are required, and as our analyses suggest, the nature of possible gene&#x02013;gene interaction effects in combinations of SNPs possibly in different genes are of interest. In order to verify whether these data have any prognostic significance, follow-up of clinical ischemic events has to be performed.</p><sec><title>Strengths and limitations</title><p>We conducted this study with data from six European cities, thereby providing six independent samples for testing gene&#x02013;environment interactions. We focus here on genes that, applying a meta-analytical approach across all cities, were associated with gene&#x02013;environment interactions.</p><p>The different cities, however, reflect not only a large variation of air pollution exposure, which was desirable, but also other differences possibly confounding our results. To control for this variation, we applied a two-step approach, starting with city-specific models and thereafter pooling the results and checking for evidence of heterogeneity. This test, however, suffers from low power, and the interaction effects showed some disparity across cities. We found clearer effects in Athens and Barcelona than in Helsinki or Stockholm. The southern European cities showed the highest mean levels and the greatest variability in CO levels, whereas Stockholm and Helsinki showed very little variation and considerably lower mean levels. A sensitivity analysis excluding Athens did reduce the effect estimates for CO and increased the <italic>p</italic>-values of interaction, whereas results for NO<sub>2</sub> and PM<sub>2.5</sub> were essentially unchanged (data not shown). However, we present here a pooled analysis of six independently conducted studies based on a common protocol. Therefore, we regard the <italic>a priori</italic> planned analyses as valid, which include all cities, and especially those with the large exposure contrasts and therefore more power. By and large, the effects for CO were corroborated by those for NO<sub>2</sub>. The remaining differences might be attributed to possible differences in measurement error for the pollutants, as well as possible differences in how representative the fixed monitors are of urban background levels of the various pollutants. The low-risk allele showed point estimates below zero for the <italic>IL6</italic> SNP and the combined SNPs in relation to increased CO, for which we have no clear explanation, but because we found no such tendency for the same genotypes in relation to NO<sub>2</sub>, this may be a chance finding. The temporal relationship between exposure and effect within 12 hr generally fits the expected rise and fall of IL-6 response in the bloodstream. A fair amount of measurement error was seen for IL-6, but we expect that this would not be associated with air pollution levels and therefore would lead to nondifferential misclassification, potentially attenuating our results.</p><p>We had expected a stronger main effect of CO and NO<sub>2</sub> on IL-6 levels, but because air pollution is strongly linked to cardiovascular mortality, survivors of MI&#x02014;although at high absolute risk for future cardiovascular events&#x02014;may be less susceptible to the effects of air pollution in a relative sense than the general population. Nevertheless, our results indicate that groups of these individuals identified by specific genotypes are at increased risk of a systemic inflammatory response in association with exposure to continuous ambient air pollution. Should this increase in IL-6 be confirmed to have prognostic implications, these individuals could be identified and protected with counseling such as avoidance of traffic or going outdoors at periods of high risk, for example, within the first month after an MI or during highly polluted days. Furthermore, they might be helped by more rigorous medication.</p></sec></sec><sec><title>Conclusion</title><p>The results support our hypothesis that the effect of air pollution on inflammation may be stronger in certain genetic subpopulations of cardiac patients. Polymorphisms in the <italic>IL6</italic> genes modified the IL-6 response when exposed to increased air pollution in the 6&#x02013;11 hr period preceding sampling, consistent with biological expectation. The role of <italic>FGB</italic> rs1800790 also seemed important, although the rapid effect was unexpected. Combining these polymorphisms also showed a gene&#x02013;gene interaction, possibly implicating that one-sixth of the population of MI survivors is at particular risk for effects of air pollution. Whether these differences in air-pollution&#x02013;mediated inflammation have any prognostic importance remains to be clarified, as well as the possible role of these polymorphisms in air pollution effects on earlier stages of cardiovascular morbidity.</p></sec></body><back><fn-group><fn><p>Supplemental Material is available online (doi: 10.1289/ehp.0800370.S1 via <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/">http://dx.doi.org/</ext-link>)</p></fn><fn><p>The AIRGENE study was funded by the European Union&#x02019;s 5th Framework Program, key action number 4: &#x0201c;Environment and Health,&#x0201d; contract number QLRT-2002-02236. The statistical and genetic group was funded by the National Genome Research Net of the German Ministry of Education and Research, the &#x0201c;Sonderforschungsbereich-SFB-386,&#x0201d; and the Munich Center of Health of the Ludwig-Maximilians-Universit&#x000e4;t M&#x000fc;nchen.</p></fn></fn-group><ref-list><title>References</title><ref id="b1-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anonymous</surname></name></person-group><year>2000</year><article-title>Myocardial infarction redefined&#x02014;a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction</article-title><source>Eur Heart J</source><volume>21</volume><issue>18</issue><fpage>1502</fpage><lpage>1513</lpage><pub-id pub-id-type="pmid">10973764</pub-id></mixed-citation></ref><ref id="b2-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennermo</surname><given-names>M</given-names></name><name><surname>Held</surname><given-names>C</given-names></name><name><surname>Green</surname><given-names>F</given-names></name><name><surname>Strandberg</surname><given-names>LE</given-names></name><name><surname>Ericsson</surname><given-names>CG</given-names></name><name><surname>Hansson</surname><given-names>LO</given-names></name><etal/></person-group><year>2004</year><article-title>Prognostic value of plasma interleukin-6 concentrations and the &#x02013;174 G &#x0003e; C and &#x02013;572 G &#x0003e; C promoter polymorphisms of the interleukin-6 gene in patients with acute myocardial infarction treated with thrombolysis</article-title><source>Atherosclerosis</source><volume>174</volume><issue>1</issue><fpage>157</fpage><lpage>163</lpage><pub-id pub-id-type="pmid">15135265</pub-id></mixed-citation></ref><ref id="b3-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brook</surname><given-names>RD</given-names></name><name><surname>Franklin</surname><given-names>B</given-names></name><name><surname>Cascio</surname><given-names>W</given-names></name><name><surname>Hong</surname><given-names>Y</given-names></name><name><surname>Howard</surname><given-names>G</given-names></name><name><surname>Lipsett</surname><given-names>M</given-names></name><etal/></person-group><year>2004</year><article-title>Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association</article-title><source>Circulation</source><volume>109</volume><issue>21</issue><fpage>2655</fpage><lpage>2671</lpage><pub-id pub-id-type="pmid">15173049</pub-id></mixed-citation></ref><ref id="b4-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burzotta</surname><given-names>F</given-names></name><name><surname>Iacoviello</surname><given-names>L</given-names></name><name><surname>Di Castelnuovo</surname><given-names>A</given-names></name><name><surname>Glieca</surname><given-names>F</given-names></name><name><surname>Luciani</surname><given-names>N</given-names></name><name><surname>Zamparelli</surname><given-names>R</given-names></name><etal/></person-group><year>2001</year><article-title>Relation of the &#x02013;174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revasculari zation</article-title><source>Am J Cardiol</source><volume>88</volume><issue>10</issue><fpage>1125</fpage><lpage>1128</lpage><pub-id pub-id-type="pmid">11703956</pub-id></mixed-citation></ref><ref id="b5-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chuang</surname><given-names>KJ</given-names></name><name><surname>Coull</surname><given-names>BA</given-names></name><name><surname>Zanobetti</surname><given-names>A</given-names></name><name><surname>Suh</surname><given-names>H</given-names></name><name><surname>Schwartz</surname><given-names>J</given-names></name><name><surname>Stone</surname><given-names>PH</given-names></name><etal/></person-group><year>2008</year><article-title>Particulate air pollution as a risk factor for ST-segment depression in patients with coronary artery disease</article-title><source>Circulation</source><volume>118</volume><issue>13</issue><fpage>1314</fpage><lpage>1320</lpage><pub-id pub-id-type="pmid">18779445</pub-id></mixed-citation></ref><ref id="b6-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dales</surname><given-names>R</given-names></name></person-group><year>2004</year><article-title>Ambient carbon monoxide may influence heart rate variability in subjects with coronary artery disease</article-title><source>J Occup Environ Med</source><volume>46</volume><issue>12</issue><fpage>1217</fpage><lpage>1221</lpage><pub-id pub-id-type="pmid">15591973</pub-id></mixed-citation></ref><ref id="b7-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalmon</surname><given-names>J</given-names></name><name><surname>Laurent</surname><given-names>M</given-names></name><name><surname>Courtois</surname><given-names>G</given-names></name></person-group><year>1993</year><article-title>The human beta fibrinogen promoter contains a hepatocyte nuclear factor 1- dependent interleukin-6-responsive element</article-title><source>Mol Cell Biol</source><volume>13</volume><issue>2</issue><fpage>1183</fpage><lpage>1193</lpage><pub-id pub-id-type="pmid">8423785</pub-id></mixed-citation></ref><ref id="b8-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donaldson</surname><given-names>K</given-names></name><name><surname>Stone</surname><given-names>V</given-names></name><name><surname>Borm</surname><given-names>PJ</given-names></name><name><surname>Jimenez</surname><given-names>LA</given-names></name><name><surname>Gilmour</surname><given-names>PS</given-names></name><name><surname>Schins</surname><given-names>RP</given-names></name><etal/></person-group><year>2003</year><article-title>Oxidative stress and calcium signaling in the adverse effects of environmental particles (PM10)</article-title><source>Free Radic Biol Med</source><volume>34</volume><issue>11</issue><fpage>1369</fpage><lpage>1382</lpage><pub-id pub-id-type="pmid">12757847</pub-id></mixed-citation></ref><ref id="b9-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacquemin</surname><given-names>B</given-names></name><name><surname>Antoniades</surname><given-names>C</given-names></name><name><surname>Nyberg</surname><given-names>F</given-names></name><name><surname>Plana</surname><given-names>E</given-names></name><name><surname>Muller</surname><given-names>M</given-names></name><name><surname>Greven</surname><given-names>S</given-names></name><etal/></person-group><year>2008</year><article-title>Common genetic polymorphisms and haplotypes of fibrinogen alpha, beta, and gamma chains affect fibrinogen levels and the response to proinflammatory stimulation in myocardial infarction survivors: the AIRGENE study</article-title><source>J Am Coll Cardiol</source><volume>52</volume><issue>11</issue><fpage>941</fpage><lpage>952</lpage><pub-id pub-id-type="pmid">18772067</pub-id></mixed-citation></ref><ref id="b10-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katsouyanni</surname><given-names>K</given-names></name><name><surname>Zmirou</surname><given-names>D</given-names></name><name><surname>Spix</surname><given-names>C</given-names></name><name><surname>Sunyer</surname><given-names>J</given-names></name><name><surname>Schouten</surname><given-names>JP</given-names></name><name><surname>Ponka</surname><given-names>A</given-names></name><etal/></person-group><year>1995</year><article-title>Short-term effects of air pollution on health: a European approach using epidemiological time-series data. The APHEA project: background, objectives, design</article-title><source>Eur Respir J</source><volume>8</volume><issue>6</issue><fpage>1030</fpage><lpage>1038</lpage><pub-id pub-id-type="pmid">7589368</pub-id></mixed-citation></ref><ref id="b11-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleeberger</surname><given-names>SR</given-names></name></person-group><year>2003</year><article-title>Genetic aspects of susceptibility to air pollution</article-title><source>Eur Respir J</source><volume>40</volume><issue>suppl</issue><fpage>52s</fpage><lpage>56s</lpage></mixed-citation></ref><ref id="b12-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ljungman</surname><given-names>P</given-names></name><name><surname>Bellander</surname><given-names>T</given-names></name><name><surname>Nyberg</surname><given-names>F</given-names></name><name><surname>Lampa</surname><given-names>E</given-names></name><name><surname>Jacquemin</surname><given-names>B</given-names></name><name><surname>Kolz</surname><given-names>M</given-names></name><etal/></person-group><year>2009</year><article-title>DNA variants, plasma levels and variability of Interleukin-6 in myocardial infarction survivors: results from the AIRGENE study</article-title><source>Thromb Res</source><volume>124</volume><issue>1</issue><fpage>57</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">19056105</pub-id></mixed-citation></ref><ref id="b13-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>London</surname><given-names>SJ</given-names></name></person-group><year>2007</year><article-title>Gene-air pollution interactions in asthma</article-title><source>Proc Am Thorac Soc</source><volume>4</volume><issue>3</issue><fpage>217</fpage><lpage>220</lpage><pub-id pub-id-type="pmid">17607002</pub-id></mixed-citation></ref><ref id="b14-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mannila</surname><given-names>MN</given-names></name><name><surname>Eriksson</surname><given-names>P</given-names></name><name><surname>Leander</surname><given-names>K</given-names></name><name><surname>Wiman</surname><given-names>B</given-names></name><name><surname>de Faire</surname><given-names>U</given-names></name><name><surname>Hamsten</surname><given-names>A</given-names></name><etal/></person-group><year>2007</year><article-title>The association between fibrinogen haplotypes and myocardial infarction in men is partly mediated through pleiotropic effects on the serum IL-6 concentration</article-title><source>J Intern Med</source><volume>261</volume><issue>2</issue><fpage>138</fpage><lpage>147</lpage><pub-id pub-id-type="pmid">17241179</pub-id></mixed-citation></ref><ref id="b15-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mannila</surname><given-names>MN</given-names></name><name><surname>Silveira</surname><given-names>A</given-names></name><name><surname>Hawe</surname><given-names>E</given-names></name><name><surname>Eriksson</surname><given-names>P</given-names></name><name><surname>Aillaud</surname><given-names>MF</given-names></name><name><surname>Juhan-Vague</surname><given-names>I</given-names></name><etal/></person-group><year>2004</year><article-title>Plasma fibrinogen concentration predicts the risk of myocardial infarction differently in various parts of Europe: effects of beta-fibrinogen genotype and environmental factors. The HIFMECH study</article-title><source>Thromb Haemost</source><volume>92</volume><issue>6</issue><fpage>1240</fpage><lpage>1249</lpage><pub-id pub-id-type="pmid">15583729</pub-id></mixed-citation></ref><ref id="b16-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGrath</surname><given-names>JJ</given-names></name></person-group><year>2000</year><article-title>Biological plausibility for carbon monoxide as a copollutant in PM epidemiologic studies</article-title><source>Inhal Toxicol</source><volume>12</volume><issue>suppl 4</issue><fpage>91</fpage><lpage>107</lpage><pub-id pub-id-type="pmid">12881888</pub-id></mixed-citation></ref><ref id="b17-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>NL</given-names></name><name><surname>Tornqvist</surname><given-names>H</given-names></name><name><surname>Gonzalez</surname><given-names>MC</given-names></name><name><surname>Vink</surname><given-names>E</given-names></name><name><surname>Robinson</surname><given-names>SD</given-names></name><name><surname>Soderberg</surname><given-names>S</given-names></name><etal/></person-group><year>2007</year><article-title>Ischemic and thrombotic effects of dilute diesel-exhaust inhalation in men with coronary heart disease</article-title><source>N Engl J Med</source><volume>357</volume><issue>11</issue><fpage>1075</fpage><lpage>1082</lpage><pub-id pub-id-type="pmid">17855668</pub-id></mixed-citation></ref><ref id="b18-ehp-117-1373"><mixed-citation publication-type="webpage"><collab>National Center for Biotechnology Information</collab><year>2009</year><source>Genbank Overview</source><comment>Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/Genbank/">http://www.ncbi.nlm.nih.gov/Genbank/</ext-link></comment><date-in-citation>[accessed 6 June 2009]</date-in-citation></mixed-citation></ref><ref id="b19-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niwa</surname><given-names>Y</given-names></name><name><surname>Hiura</surname><given-names>Y</given-names></name><name><surname>Sawamura</surname><given-names>H</given-names></name><name><surname>Iwai</surname><given-names>N</given-names></name></person-group><year>2008</year><article-title>Inhalation exposure to carbon black induces inflammatory response in rats</article-title><source>Circ J</source><volume>72</volume><issue>1</issue><fpage>144</fpage><lpage>149</lpage><pub-id pub-id-type="pmid">18159116</pub-id></mixed-citation></ref><ref id="b20-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>A</given-names></name><name><surname>Dockery</surname><given-names>DW</given-names></name><name><surname>Muller</surname><given-names>JE</given-names></name><name><surname>Mittleman</surname><given-names>MA</given-names></name></person-group><year>2001</year><article-title>Increased particulate air pollution and the triggering of myocardial infarction</article-title><source>Circulation</source><volume>103</volume><issue>23</issue><fpage>2810</fpage><lpage>2815</lpage><pub-id pub-id-type="pmid">11401937</pub-id></mixed-citation></ref><ref id="b21-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>A</given-names></name><name><surname>Greven</surname><given-names>S</given-names></name><name><surname>Heid</surname><given-names>IM</given-names></name><name><surname>Baldari</surname><given-names>F</given-names></name><name><surname>Breitner</surname><given-names>S</given-names></name><name><surname>Bellander</surname><given-names>T</given-names></name><etal/></person-group><year>2009</year><article-title>Fibrinogen genes modify the fibrinogen response to ambient particulate matter</article-title><source>Am J Respir Crit Care Med</source><volume>179</volume><issue>6</issue><fpage>484</fpage><lpage>491</lpage><pub-id pub-id-type="pmid">19136375</pub-id></mixed-citation></ref><ref id="b22-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>A</given-names></name><name><surname>Schneider</surname><given-names>A</given-names></name><name><surname>Greven</surname><given-names>S</given-names></name><name><surname>Bellander</surname><given-names>T</given-names></name><name><surname>Forastiere</surname><given-names>F</given-names></name><name><surname>Ibald-Mulli</surname><given-names>A</given-names></name><etal/></person-group><year>2007</year><article-title>Air pollution and inflammatory response in myocardial infarction survivors: gene-environment interactions in a high-risk group</article-title><source>Inhal Toxicol</source><volume>19</volume><issue>suppl 1</issue><fpage>161</fpage><lpage>175</lpage><pub-id pub-id-type="pmid">17886064</pub-id></mixed-citation></ref><ref id="b23-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quay</surname><given-names>JL</given-names></name><name><surname>Reed</surname><given-names>W</given-names></name><name><surname>Samet</surname><given-names>J</given-names></name><name><surname>Devlin</surname><given-names>RB</given-names></name></person-group><year>1998</year><article-title>Air pollution particles induce IL-6 gene expression in human airway epithelial cells via NF-kappaB activation</article-title><source>Am J Respir Cell Mol Biol</source><volume>19</volume><issue>1</issue><fpage>98</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">9651185</pub-id></mixed-citation></ref><ref id="b24-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rattazzi</surname><given-names>M</given-names></name><name><surname>Puato</surname><given-names>M</given-names></name><name><surname>Faggin</surname><given-names>E</given-names></name><name><surname>Bertipaglia</surname><given-names>B</given-names></name><name><surname>Zambon</surname><given-names>A</given-names></name><name><surname>Pauletto</surname><given-names>P</given-names></name></person-group><year>2003</year><article-title>C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders?</article-title><source>J Hypertens</source><volume>21</volume><issue>10</issue><fpage>1787</fpage><lpage>1803</lpage><pub-id pub-id-type="pmid">14508181</pub-id></mixed-citation></ref><ref id="b25-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritchie</surname><given-names>DG</given-names></name><name><surname>Levy</surname><given-names>BA</given-names></name><name><surname>Adams</surname><given-names>MA</given-names></name><name><surname>Fuller</surname><given-names>GM</given-names></name></person-group><year>1982</year><article-title>Regulation of fibrinogen synthesis by plasmin-derived fragments of fibrinogen and fibrin: an indirect feedback pathway</article-title><source>Proc Natl Acad Sci USA</source><volume>79</volume><issue>5</issue><fpage>1530</fpage><lpage>1534</lpage><pub-id pub-id-type="pmid">6461860</pub-id></mixed-citation></ref><ref id="b26-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robson</surname><given-names>SC</given-names></name><name><surname>Shephard</surname><given-names>EG</given-names></name><name><surname>Kirsch</surname><given-names>RE</given-names></name></person-group><year>1994</year><article-title>Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1 beta, IL-6 and plasminogen activator inhibitors from monocytes in vitro</article-title><source>Br J Haematol</source><volume>86</volume><issue>2</issue><fpage>322</fpage><lpage>326</lpage><pub-id pub-id-type="pmid">8199021</pub-id></mixed-citation></ref><ref id="b27-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romieu</surname><given-names>I</given-names></name><name><surname>Ramirez-Aguilar</surname><given-names>M</given-names></name><name><surname>Sienra-Monge</surname><given-names>JJ</given-names></name><name><surname>Moreno-Macias</surname><given-names>H</given-names></name><name><surname>del Rio-Navarro</surname><given-names>BE</given-names></name><name><surname>David</surname><given-names>G</given-names></name><etal/></person-group><year>2006</year><article-title>GSTM1 and GSTP1 and respiratory health in asthmatic children exposed to ozone</article-title><source>Eur Respir J</source><volume>28</volume><issue>5</issue><fpage>953</fpage><lpage>959</lpage><pub-id pub-id-type="pmid">16870661</pub-id></mixed-citation></ref><ref id="b28-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>R&#x000fc;ckerl</surname><given-names>R</given-names></name><name><surname>Greven</surname><given-names>S</given-names></name><name><surname>Ljungman</surname><given-names>P</given-names></name><name><surname>Aalto</surname><given-names>P</given-names></name><name><surname>Antoniades</surname><given-names>C</given-names></name><name><surname>Bellander</surname><given-names>T</given-names></name><etal/></person-group><year>2007</year><article-title>Air pollution and inflammation (interleukin-6, C-reactive protein, fibrinogen) in myocardial infarction survivors</article-title><source>Environ Health Perspect</source><volume>115</volume><fpage>1072</fpage><lpage>1080</lpage><pub-id pub-id-type="pmid">17637925</pub-id></mixed-citation></ref><ref id="b29-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>R&#x000fc;ckerl</surname><given-names>R</given-names></name><name><surname>Ibald-Mulli</surname><given-names>A</given-names></name><name><surname>Koenig</surname><given-names>W</given-names></name><name><surname>Schneider</surname><given-names>A</given-names></name><name><surname>Woelke</surname><given-names>G</given-names></name><name><surname>Cyrys</surname><given-names>J</given-names></name><etal/></person-group><year>2006</year><article-title>Air pollution and markers of inflammation and coagulation in patients with coronary heart disease</article-title><source>Am J Respir Crit Care Med</source><volume>173</volume><issue>4</issue><fpage>432</fpage><lpage>441</lpage><pub-id pub-id-type="pmid">16293802</pub-id></mixed-citation></ref><ref id="b30-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarnat</surname><given-names>JA</given-names></name><name><surname>Brown</surname><given-names>KW</given-names></name><name><surname>Schwartz</surname><given-names>J</given-names></name><name><surname>Coull</surname><given-names>BA</given-names></name><name><surname>Koutrakis</surname><given-names>P</given-names></name></person-group><year>2005</year><article-title>Ambient gas concentrations and personal particulate matter exposures: implications for studying the health effects of particles</article-title><source>Epidemiology</source><volume>16</volume><issue>3</issue><fpage>385</fpage><lpage>395</lpage><pub-id pub-id-type="pmid">15824556</pub-id></mixed-citation></ref><ref id="b31-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>J</given-names></name></person-group><year>2001</year><article-title>Air pollution and blood markers of cardiovascular risk</article-title><source>Environ Health Perspect</source><volume>109</volume><issue>suppl 3</issue><fpage>405</fpage><lpage>409</lpage><pub-id pub-id-type="pmid">11427390</pub-id></mixed-citation></ref><ref id="b32-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>SK</given-names></name><name><surname>O&#x02019;Neill</surname><given-names>MS</given-names></name><name><surname>Vokonas</surname><given-names>PS</given-names></name><name><surname>Sparrow</surname><given-names>D</given-names></name><name><surname>Weiss</surname><given-names>S</given-names></name><etal/></person-group><year>2005</year><article-title>Glutathione-S-transferase M1, obesity, statins, and autonomic effects of particles: gene-by-drug-by-environment interaction</article-title><source>Am J Respir Crit Care Med</source><volume>172</volume><issue>12</issue><fpage>1529</fpage><lpage>1533</lpage><pub-id pub-id-type="pmid">16020798</pub-id></mixed-citation></ref><ref id="b33-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>J</given-names></name><name><surname>Sarnat</surname><given-names>JA</given-names></name><name><surname>Coull</surname><given-names>BA</given-names></name><name><surname>Wilson</surname><given-names>WE</given-names></name></person-group><year>2007</year><article-title>Effects of exposure measurement error on particle matter epidemiology: a simulation using data from a panel study in Baltimore, MD</article-title><source>J Expo Sci Environ Epidemiol</source><volume>17</volume><issue>suppl 2</issue><fpage>S2</fpage><lpage>S10</lpage><pub-id pub-id-type="pmid">18079760</pub-id></mixed-citation></ref><ref id="b34-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szaba</surname><given-names>FM</given-names></name><name><surname>Smiley</surname><given-names>ST</given-names></name></person-group><year>2002</year><article-title>Roles for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo</article-title><source>Blood</source><volume>99</volume><issue>3</issue><fpage>1053</fpage><lpage>1059</lpage><pub-id pub-id-type="pmid">11807012</pub-id></mixed-citation></ref><ref id="b35-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Houwelingen</surname><given-names>HC</given-names></name><name><surname>Arends</surname><given-names>LR</given-names></name><name><surname>Stijnen</surname><given-names>T</given-names></name></person-group><year>2002</year><article-title>Advanced methods in meta-analysis: multivariate approach and meta-regression</article-title><source>Stat Med</source><volume>21</volume><issue>4</issue><fpage>589</fpage><lpage>624</lpage><pub-id pub-id-type="pmid">11836738</pub-id></mixed-citation></ref><ref id="b36-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vogel</surname><given-names>CF</given-names></name><name><surname>Sciullo</surname><given-names>E</given-names></name><name><surname>Wong</surname><given-names>P</given-names></name><name><surname>Kuzmicky</surname><given-names>P</given-names></name><name><surname>Kado</surname><given-names>N</given-names></name><name><surname>Matsumura</surname><given-names>F</given-names></name></person-group><year>2005</year><article-title>Induction of proinflammatory cytokines and C-reactive protein in human macrophage cell line U937 exposed to air pollution particulates</article-title><source>Environ Health Perspect</source><volume>113</volume><fpage>1536</fpage><lpage>1541</lpage><pub-id pub-id-type="pmid">16263508</pub-id></mixed-citation></ref><ref id="b37-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watterson</surname><given-names>TL</given-names></name><name><surname>Sorensen</surname><given-names>J</given-names></name><name><surname>Martin</surname><given-names>R</given-names></name><name><surname>Coulombe</surname><given-names>RA</given-names><suffix>Jr</suffix></name></person-group><year>2007</year><article-title>Effects of PM2.5 collected from Cache Valley Utah on genes associated with the inflammatory response in human lung cells</article-title><source>J Toxicol Environ Health A</source><volume>70</volume><issue>20</issue><fpage>1731</fpage><lpage>1744</lpage><pub-id pub-id-type="pmid">17885930</pub-id></mixed-citation></ref><ref id="b38-ehp-117-1373"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zanobetti</surname><given-names>A</given-names></name><name><surname>Schwartz</surname><given-names>J</given-names></name></person-group><year>2005</year><article-title>The effect of particulate air pollution on emergency admissions for myocardial infarction: a multicity case-crossover analysis</article-title><source>Environ Health Perspect</source><volume>113</volume><fpage>978</fpage><lpage>982</lpage><pub-id pub-id-type="pmid">16079066</pub-id></mixed-citation></ref></ref-list></back><floats-group><fig id="f1-ehp-117-1373" position="float"><label>Figure 1</label><caption><p>Modification by <italic>IL6</italic> rs2069832 (<italic>A</italic>) and <italic>FGB</italic> rs1800790 (<italic>B</italic>) genotypes of IL-6 response to increased 24-hr average ambient CO, NO<sub>2</sub>, ultrafine PM (PNC), and PM<sub>2.5</sub> immediately preceding blood withdrawal (1, major allele; 2, minor allele). Error bars indicate 95% CIs; <italic>p</italic>-values are for significance of the inter action term. Interquartile ranges: CO, 34.0 mg/m<sup>3</sup>; NO<sub>2</sub>, 15.9 &#x003bc;g/m<sup>3</sup>; PNC, 11,852/cm<sup>3</sup>; PM<sub>2.5</sub>, 11.0 &#x003bc;g/m<sup>3</sup>; PM<sub>10</sub>, 17.4 &#x003bc;g/m<sup>3</sup>.</p><p>*Heterogeneity of the city-specific effect estimates with a <italic>p</italic>-value &#x0003c; 0.1.</p></caption><graphic xlink:href="ehp-117-1373f1"/></fig><fig id="f2-ehp-117-1373" position="float"><label>Figure 2</label><caption><p>(<italic>A</italic>) Construction of gene&#x02013;gene interaction variable based on relative change in plasma IL-6 in univariate gene&#x02013;environment interaction analysis of polymorphisms <italic>IL6</italic> rs2069832 and <italic>FGB</italic> rs1800790. (<italic>B</italic> ) Modification by gene&#x02013;gene interaction of <italic>IL6</italic> rs2069832 and <italic>FGB</italic> rs1800790 of IL-6 response to increased preceding ambient 24-hr air pollutant averages. Error bars indicate 95% CIs, and <italic>p</italic>-values are for significance of the interaction term. Interquartile ranges: CO, 0.34 mg/m<sup>3</sup>; NO<sub>2</sub>, 15.9 &#x003bc;g/m<sup>3</sup>; PNC, 11,852/cm<sup>3</sup>; PM<sub>2.5</sub>, 11.0 &#x003bc;g/m<sup>3</sup>; PM<sub>10</sub>, 17.4 &#x003bc;g/m<sup>3</sup>.</p><p>*Heterogeneity of the city-specific effect estimates with a <italic>p</italic>-value &#x0003c; 0.1.</p></caption><graphic xlink:href="ehp-117-1373f2"/></fig><fig id="f3-ehp-117-1373" position="float"><label>Figure 3</label><caption><p>Modification by <italic>IL6</italic> rs2069832 and <italic>FGB</italic> rs1800790 genotypes of IL-6 response to increased ambient CO and NO<sub>2</sub> in association with 6-hr exposure windows preceding blood sampling. Error bars indicate 95% CIs, and <italic>p</italic>-values are for significance of the interaction term. Interquartile ranges for 6-hr means: CO, 0.64 mg/m<sup>3</sup>; NO<sub>2</sub>, 11.5 &#x003bc;g/m<sup>3</sup>.</p><p>*Heterogeneity of the city-specific effect estimates with a <italic>p</italic>-value &#x0003c; 0.1.</p></caption><graphic xlink:href="ehp-117-1373f3"/></fig><table-wrap id="t1-ehp-117-1373" position="float"><label>Table 1</label><caption><p>Data on patient characteristics, IL-6 measurements, and air pollution concentrations in the AIRGENE study.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Variable</th><th align="center" rowspan="1" colspan="1">Helsinki</th><th align="center" rowspan="1" colspan="1">Stockholm</th><th align="center" rowspan="1" colspan="1">Augsburg</th><th align="center" rowspan="1" colspan="1">Rome</th><th align="center" rowspan="1" colspan="1">Barcelona</th><th align="center" rowspan="1" colspan="1">Athens</th><th align="center" rowspan="1" colspan="1">Total</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">No.</td><td align="center" rowspan="1" colspan="1">182</td><td align="center" rowspan="1" colspan="1">193</td><td align="center" rowspan="1" colspan="1">187</td><td align="center" rowspan="1" colspan="1">132</td><td align="center" rowspan="1" colspan="1">160</td><td align="center" rowspan="1" colspan="1">101</td><td align="center" rowspan="1" colspan="1">955</td></tr><tr><td align="left" rowspan="1" colspan="1">Sex (% male)</td><td align="center" rowspan="1" colspan="1">69.8</td><td align="center" rowspan="1" colspan="1">71.0</td><td align="center" rowspan="1" colspan="1">81.8</td><td align="center" rowspan="1" colspan="1">87.1</td><td align="center" rowspan="1" colspan="1">84.4</td><td align="center" rowspan="1" colspan="1">86.1</td><td align="center" rowspan="1" colspan="1">79.0</td></tr><tr><td align="left" rowspan="1" colspan="1">Age (years)<xref ref-type="table-fn" rid="tfn1-ehp-117-1373">a</xref></td><td align="center" rowspan="1" colspan="1">64.4 (45&#x02013;78)</td><td align="center" rowspan="1" colspan="1">64.0 (38&#x02013;76)</td><td align="center" rowspan="1" colspan="1">61.9 (39&#x02013;76)</td><td align="center" rowspan="1" colspan="1">62.5 (39&#x02013;79)</td><td align="center" rowspan="1" colspan="1">62.1 (37&#x02013;81)</td><td align="center" rowspan="1" colspan="1">54.5 (38&#x02013;75)</td><td align="center" rowspan="1" colspan="1">62.2 (37&#x02013;81)</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)<xref ref-type="table-fn" rid="tfn1-ehp-117-1373">a</xref></td><td align="center" rowspan="1" colspan="1">28.8 (19.1&#x02013;48.9)</td><td align="center" rowspan="1" colspan="1">27.6 (17.5&#x02013;43.3)</td><td align="center" rowspan="1" colspan="1">28.9 (19.1&#x02013;48.4)</td><td align="center" rowspan="1" colspan="1">27.7 (19.0&#x02013;39.4)</td><td align="center" rowspan="1" colspan="1">28.8 (19.4&#x02013;43.5)</td><td align="center" rowspan="1" colspan="1">28.8 (20.9&#x02013;46.4)</td><td align="center" rowspan="1" colspan="1">28.4 (17.5&#x02013;48.9)</td></tr><tr><td align="left" rowspan="1" colspan="1">HDL/total cholesterol<xref ref-type="table-fn" rid="tfn1-ehp-117-1373">a</xref></td><td align="center" rowspan="1" colspan="1">0.3 (0.1&#x02013;0.6)</td><td align="center" rowspan="1" colspan="1">0.3 (0.1&#x02013;0.6)</td><td align="center" rowspan="1" colspan="1">0.3 (0.1&#x02013;0.5)</td><td align="center" rowspan="1" colspan="1">0.2 (0.1&#x02013;0.5)</td><td align="center" rowspan="1" colspan="1">0.3 (0.1&#x02013;0.5)</td><td align="center" rowspan="1" colspan="1">0.2 (0.1&#x02013;0.6)</td><td align="center" rowspan="1" colspan="1">0.3 (0.1&#x02013;0.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">HbA1c (%)<xref ref-type="table-fn" rid="tfn1-ehp-117-1373">a</xref></td><td align="center" rowspan="1" colspan="1">5.9 (4.7&#x02013;9.2)</td><td align="center" rowspan="1" colspan="1">5.1 (3.8&#x02013;9.9)</td><td align="center" rowspan="1" colspan="1">5.6 (4.7&#x02013;9.8)</td><td align="center" rowspan="1" colspan="1">5.4 (2.8&#x02013;8.7)</td><td align="center" rowspan="1" colspan="1">5.1 (3.8&#x02013;9.8)</td><td align="center" rowspan="1" colspan="1">5.9 (3.7&#x02013;10.5)</td><td align="center" rowspan="1" colspan="1">5.5 (2.8&#x02013;10.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">NT-proBNP (pg/mL)<xref ref-type="table-fn" rid="tfn1-ehp-117-1373">a</xref></td><td align="center" rowspan="1" colspan="1">392.9 (10.8&#x02013;3,799)</td><td align="center" rowspan="1" colspan="1">330.4 (14.0&#x02013;3,348)</td><td align="center" rowspan="1" colspan="1">482.5 (12.5&#x02013;9,308)</td><td align="center" rowspan="1" colspan="1">405.0 (19.1&#x02013;6,174)</td><td align="center" rowspan="1" colspan="1">380.6 (11.3&#x02013;7,057)</td><td align="center" rowspan="1" colspan="1">314.9 (11.0&#x02013;4,855)</td><td align="center" rowspan="1" colspan="1">389.1 (10.8&#x02013;9,308)</td></tr><tr><td align="left" rowspan="1" colspan="1">Current smokers (%)</td><td align="center" rowspan="1" colspan="1">1.7</td><td align="center" rowspan="1" colspan="1">0.5</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">9.1</td><td align="center" rowspan="1" colspan="1">13.8</td><td align="center" rowspan="1" colspan="1">38.6</td><td align="center" rowspan="1" colspan="1">8.1</td></tr><tr><td align="left" rowspan="1" colspan="1">Pack-years (cigarettes only)<xref ref-type="table-fn" rid="tfn1-ehp-117-1373">a</xref></td><td align="center" rowspan="1" colspan="1">9.2 (0&#x02013;65.0)</td><td align="center" rowspan="1" colspan="1">12.2 (0&#x02013;73.8)</td><td align="center" rowspan="1" colspan="1">15.2 (0&#x02013;205.2)</td><td align="center" rowspan="1" colspan="1">22.0 (0&#x02013;171.8)</td><td align="center" rowspan="1" colspan="1">28.4 (0&#x02013;193.2)</td><td align="center" rowspan="1" colspan="1">35.6 (0&#x02013;174.0)</td><td align="center" rowspan="1" colspan="1">18.8 (0&#x02013;205.2)</td></tr><tr><td align="left" rowspan="1" colspan="1">Time between last MI and study start (years)<xref ref-type="table-fn" rid="tfn1-ehp-117-1373">a</xref></td><td align="center" rowspan="1" colspan="1">2.7 (0.6&#x02013;5.8)</td><td align="center" rowspan="1" colspan="1">2.3 (0.6&#x02013;3.9)</td><td align="center" rowspan="1" colspan="1">2.1 (0.5&#x02013;3.4)</td><td align="center" rowspan="1" colspan="1">2.7 (0.4&#x02013;6.0)</td><td align="center" rowspan="1" colspan="1">2.2 (0.4&#x02013;5.9)</td><td align="center" rowspan="1" colspan="1">2.4 (0.5&#x02013;5.0)</td><td align="center" rowspan="1" colspan="1">2.4 (0.4&#x02013;6.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">First MI (%)</td><td align="center" rowspan="1" colspan="1">81.9</td><td align="center" rowspan="1" colspan="1">86.5</td><td align="center" rowspan="1" colspan="1">88.2</td><td align="center" rowspan="1" colspan="1">87.1</td><td align="center" rowspan="1" colspan="1">85.6</td><td align="center" rowspan="1" colspan="1">81.2</td><td align="center" rowspan="1" colspan="1">85.3</td></tr><tr><td colspan="8" align="left" rowspan="1">Self-reported history<xref ref-type="table-fn" rid="tfn2-ehp-117-1373">b</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Arrhythmia (%)</td><td align="center" rowspan="1" colspan="1">1.7</td><td align="center" rowspan="1" colspan="1">1.8</td><td align="center" rowspan="1" colspan="1">1.8</td><td align="center" rowspan="1" colspan="1">1.8</td><td align="center" rowspan="1" colspan="1">1.9</td><td align="center" rowspan="1" colspan="1">1.8</td><td align="center" rowspan="1" colspan="1">1.8</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Chronic bronchitis (%)</td><td align="center" rowspan="1" colspan="1">1.8</td><td align="center" rowspan="1" colspan="1">1.8</td><td align="center" rowspan="1" colspan="1">1.9</td><td align="center" rowspan="1" colspan="1">1.9</td><td align="center" rowspan="1" colspan="1">2.0</td><td align="center" rowspan="1" colspan="1">2.0</td><td align="center" rowspan="1" colspan="1">1.9</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Hypertension (%)</td><td align="center" rowspan="1" colspan="1">1.5</td><td align="center" rowspan="1" colspan="1">1.5</td><td align="center" rowspan="1" colspan="1">1.5</td><td align="center" rowspan="1" colspan="1">1.4</td><td align="center" rowspan="1" colspan="1">1.5</td><td align="center" rowspan="1" colspan="1">1.4</td><td align="center" rowspan="1" colspan="1">1.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Blood samples (<italic>n</italic>)</td><td align="center" rowspan="1" colspan="1">1,081</td><td align="center" rowspan="1" colspan="1">1,146</td><td align="center" rowspan="1" colspan="1">1,067</td><td align="center" rowspan="1" colspan="1">728</td><td align="center" rowspan="1" colspan="1">1,059</td><td align="center" rowspan="1" colspan="1">458</td><td align="center" rowspan="1" colspan="1">5,539</td></tr><tr><td align="left" rowspan="1" colspan="1">IL-6 (pg/mL)<xref ref-type="table-fn" rid="tfn3-ehp-117-1373">c</xref></td><td align="center" rowspan="1" colspan="1">3.1 (0.9&#x02013;19.7)</td><td align="center" rowspan="1" colspan="1">2.6 (0.5&#x02013;24.4)</td><td align="center" rowspan="1" colspan="1">2.5 (0.6&#x02013;11.8)</td><td align="center" rowspan="1" colspan="1">3.0 (1.0&#x02013;61.4)</td><td align="center" rowspan="1" colspan="1">3.5 (0.8&#x02013;28.5)</td><td align="center" rowspan="1" colspan="1">3.0 (0.8&#x02013;22.4)</td><td align="center" rowspan="1" colspan="1">3.0 (0.5&#x02013;61.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">Air pollution measurement (study period)<xref ref-type="table-fn" rid="tfn4-ehp-117-1373">d</xref></td><td align="center" rowspan="1" colspan="1">5 Sep 2003 to 2 Jun 2004</td><td align="center" rowspan="1" colspan="1">30 Aug 2003 to 24 June 2004</td><td align="center" rowspan="1" colspan="1">14 May 2003 to 24 Feb 2004</td><td align="center" rowspan="1" colspan="1">20 Sep 2003 to 15 Jul 2004</td><td align="center" rowspan="1" colspan="1">30 Aug 2003 to 16 Jun 2004</td><td align="center" rowspan="1" colspan="1">8 Sep 2003 to 30 Jul 2004</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;CO (mg/m<sup>3</sup>)</td><td align="center" rowspan="1" colspan="1">0.31 (0.26&#x02013;0.34)</td><td align="center" rowspan="1" colspan="1">0.29 (0.25&#x02013;0.34)</td><td align="center" rowspan="1" colspan="1">0.58 (0.43&#x02013;0.66)</td><td align="center" rowspan="1" colspan="1">1.40 (1.02&#x02013;1.66)</td><td align="center" rowspan="1" colspan="1">0.59 (0.45&#x02013;0.70)</td><td align="center" rowspan="1" colspan="1">1.48 (0.95&#x02013;1.68)</td><td align="center" rowspan="1" colspan="1">0.78 (0.56&#x02013;0.90)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;NO<sub>2</sub> (&#x003bc;g/m<sup>3</sup>)</td><td align="center" rowspan="1" colspan="1">28.6 (20.5&#x02013;34.6)</td><td align="center" rowspan="1" colspan="1">18.4 (12.7&#x02013;22.9)</td><td align="center" rowspan="1" colspan="1">40.0 (32.7&#x02013;46.5)</td><td align="center" rowspan="1" colspan="1">67.0 (56.7&#x02013;76.3)</td><td align="center" rowspan="1" colspan="1">50.5 (39.3&#x02013;60.4)</td><td align="center" rowspan="1" colspan="1">50.2 (42.0&#x02013;59.0)</td><td align="center" rowspan="1" colspan="1">42.4 (34.0&#x02013;49.9)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;PM<sub>2.5</sub> (&#x003bc;g/m<sup>3</sup>)</td><td align="center" rowspan="1" colspan="1">8.2 (4.7&#x02013;10.4)</td><td align="center" rowspan="1" colspan="1">8.8 (6.0&#x02013;10.3)</td><td align="center" rowspan="1" colspan="1">17.4 (12.2&#x02013;21.2)</td><td align="center" rowspan="1" colspan="1">24.6 (14.0&#x02013;30.7)</td><td align="center" rowspan="1" colspan="1">24.2 (13.5&#x02013;29.7)</td><td align="center" rowspan="1" colspan="1">23.0 (14.9&#x02013;29.1)</td><td align="center" rowspan="1" colspan="1">17.7 (10.9&#x02013;21.9)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;PM<sub>10</sub> (&#x003bc;g/m<sup>3</sup>)</td><td align="center" rowspan="1" colspan="1">17.1 (10.5&#x02013;20.7)</td><td align="center" rowspan="1" colspan="1">17.8 (11.0&#x02013;21.7)</td><td align="center" rowspan="1" colspan="1">33.1 (22.0&#x02013;42.7)</td><td align="center" rowspan="1" colspan="1">42.1 (30.6&#x02013;49.9)</td><td align="center" rowspan="1" colspan="1">40.7 (25.1&#x02013;49.2)</td><td align="center" rowspan="1" colspan="1">38.5 (27.1&#x02013;46.4)</td><td align="center" rowspan="1" colspan="1">31.6 (21.1&#x02013;38.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;PNC (per cm<sup>3</sup>)</td><td align="center" rowspan="1" colspan="1">8,534 (5,834&#x02013;10,519)</td><td align="center" rowspan="1" colspan="1">9,748 (7,247&#x02013;11,625)</td><td align="center" rowspan="1" colspan="1">11,876 (7,085&#x02013;14,440)</td><td align="center" rowspan="1" colspan="1">35,450 (21,094&#x02013;46,963)</td><td align="center" rowspan="1" colspan="1">18,133 (10,492&#x02013;24,278)</td><td align="center" rowspan="1" colspan="1">20,590 (11,872&#x02013;26,913)</td><td align="center" rowspan="1" colspan="1">17,388 (10,604&#x02013;22,456)</td></tr><tr><td colspan="8" align="left" rowspan="1">Pearson correlation</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;CO</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;NO<sub>2</sub></td><td align="center" rowspan="1" colspan="1">0.76</td><td align="center" rowspan="1" colspan="1">0.56</td><td align="center" rowspan="1" colspan="1">0.53</td><td align="center" rowspan="1" colspan="1">0.75</td><td align="center" rowspan="1" colspan="1">0.70</td><td align="center" rowspan="1" colspan="1">0.55</td><td align="center" rowspan="1" colspan="1">0.69</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;PM<sub>2.5</sub></td><td align="center" rowspan="1" colspan="1">0.38</td><td align="center" rowspan="1" colspan="1">0.53</td><td align="center" rowspan="1" colspan="1">0.61</td><td align="center" rowspan="1" colspan="1">0.70</td><td align="center" rowspan="1" colspan="1">0.26</td><td align="center" rowspan="1" colspan="1">0.45</td><td align="center" rowspan="1" colspan="1">0.55</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;PM<sub>10</sub></td><td align="center" rowspan="1" colspan="1">0.25</td><td align="center" rowspan="1" colspan="1">0.30</td><td align="center" rowspan="1" colspan="1">0.60</td><td align="center" rowspan="1" colspan="1">0.71</td><td align="center" rowspan="1" colspan="1">0.30</td><td align="center" rowspan="1" colspan="1">0.17</td><td align="center" rowspan="1" colspan="1">0.47</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;PNC</td><td align="center" rowspan="1" colspan="1">0.60</td><td align="center" rowspan="1" colspan="1">0.23</td><td align="center" rowspan="1" colspan="1">0.77</td><td align="center" rowspan="1" colspan="1">0.87</td><td align="center" rowspan="1" colspan="1">0.64</td><td align="center" rowspan="1" colspan="1">0.25</td><td align="center" rowspan="1" colspan="1">0.67</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-ehp-117-1373"><label>a</label><p>Mean (range).</p></fn><fn id="tfn2-ehp-117-1373"><label>b</label><p>Ever diagnosed by a physician.</p></fn><fn id="tfn3-ehp-117-1373"><label>c</label><p>Mean (range) of the subject-specific means based on three to eight repeated measurements.</p></fn><fn id="tfn4-ehp-117-1373"><label>d</label><p>Mean (25th&#x02013;75th percentile) for consecutive 24-hr means across study period.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2-ehp-117-1373" position="float"><label>Table 2</label><caption><p>SNPs and SNP&#x02013;IL-6 association: characteristics of the analyzed SNPs of <italic>IL6</italic>, <italic>FGB</italic>, and <italic>FGA</italic> and their association with plasma IL-6 concentrations.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" valign="bottom" colspan="1">SNP</th><th align="center" rowspan="2" valign="bottom" colspan="1">Functional region</th><th colspan="2" align="center" valign="bottom" rowspan="1">Alleles <hr/></th><th colspan="3" align="center" valign="bottom" rowspan="1">Genotype frequency [% (<italic>n</italic>)] <hr/></th><th align="center" rowspan="2" valign="bottom" colspan="1">Difference in IL-6<xref ref-type="table-fn" rid="tfn5-ehp-117-1373">a</xref> level ll [% overall mean: effect of two alleles (2 2 vs. 1 1)]</th></tr><tr><th align="center" valign="bottom" rowspan="1" colspan="1">Major (1)/Minor (2)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Minor allele frequency [% (<italic>n</italic>)]</th><th align="center" valign="bottom" rowspan="1" colspan="1">Homozygote of major allele (1 1)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Heterozygote (1 2)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Homozygote of minor allele (2 2)</th></tr></thead><tbody><tr><td colspan="8" align="left" rowspan="1"><italic>IL6</italic><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;rs2069832</td><td align="center" rowspan="1" colspan="1">Intron</td><td align="center" rowspan="1" colspan="1">G/A</td><td align="center" rowspan="1" colspan="1">40 (768)</td><td align="center" rowspan="1" colspan="1">36 (696)</td><td align="center" rowspan="1" colspan="1">47 (892)</td><td align="right" rowspan="1" colspan="1">17 (322)</td><td align="center" rowspan="1" colspan="1">13.4 (3.7 to 24.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;rs2069840</td><td align="center" rowspan="1" colspan="1">Intron</td><td align="center" rowspan="1" colspan="1">C/G</td><td align="center" rowspan="1" colspan="1">31 (602)</td><td align="center" rowspan="1" colspan="1">46 (884)</td><td align="center" rowspan="1" colspan="1">45 (850)</td><td align="right" rowspan="1" colspan="1">9 (176)</td><td align="center" rowspan="1" colspan="1">&#x02212; 9.6 (&#x02212; 17.2 to &#x02212; 1.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;rs2069845</td><td align="center" rowspan="1" colspan="1">Intron</td><td align="center" rowspan="1" colspan="1">A/G</td><td align="center" rowspan="1" colspan="1">43 (820)</td><td align="center" rowspan="1" colspan="1">33 (632)</td><td align="center" rowspan="1" colspan="1">48 (918)</td><td align="right" rowspan="1" colspan="1">19 (360)</td><td align="center" rowspan="1" colspan="1">14.6 (4.7 to 25.4)</td></tr><tr><td colspan="8" align="left" rowspan="1"><hr/></td></tr><tr><td colspan="8" align="left" rowspan="1"><italic>FGA</italic><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;rs2070011</td><td align="center" rowspan="1" colspan="1">Promoter</td><td align="center" rowspan="1" colspan="1">C/T</td><td align="center" rowspan="1" colspan="1">39 (744)</td><td align="center" rowspan="1" colspan="1">39 (738)</td><td align="center" rowspan="1" colspan="1">45 (858)</td><td align="right" rowspan="1" colspan="1">16 (314)</td><td align="center" rowspan="1" colspan="1">8.1 (&#x02212; 0.5 to 17.5)</td></tr><tr><td colspan="8" align="left" rowspan="1"><hr/></td></tr><tr><td colspan="8" align="left" rowspan="1"><italic>FGB</italic><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;rs1800790</td><td align="center" rowspan="1" colspan="1">Promoter</td><td align="center" rowspan="1" colspan="1">G/A</td><td align="center" rowspan="1" colspan="1">20 (386)</td><td align="center" rowspan="1" colspan="1">63 (1,210)</td><td align="center" rowspan="1" colspan="1">33 (628)</td><td align="right" rowspan="1" colspan="1">4 (72)</td><td align="center" rowspan="1" colspan="1">&#x02212; 5.6 (&#x02212; 14.7 to 4.4)</td></tr></tbody></table><table-wrap-foot><fn id="tfn5-ehp-117-1373"><label>a</label><p>Effect estimates and 95% CIs from linear mixed model analysis with log IL-6 as outcome, with a random effect for subject to account for repeated measurements, using an additive genetic model for the genotypes, and adjusted for age, city, glycosylated hemoglobin, number of earlier MIs, earlier diagnosed heart failure or diabetes, symptoms of phlegm, BMI, pack-years of cigarette smoking, HDL cholesterol, systolic blood pressure, alcohol intake, and log NT-proBNP.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t3-ehp-117-1373" position="float"><label>Table 3</label><caption><p>Effect of 24-hr interquartile range increase in air pollution on IL-6 plasma levels.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Air pollutant response without genetic covariate</th><th align="center" rowspan="1" colspan="1">Interquartile range increase</th><th align="center" rowspan="1" colspan="1">Change of IL-6<xref ref-type="table-fn" rid="tfn6-ehp-117-1373">a</xref> (% of overall mean per interquartile range increase)</th><th align="center" rowspan="1" colspan="1"><italic>p</italic>-Value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">CO</td><td align="center" rowspan="1" colspan="1">0.34 mg/m<sup>3</sup></td><td align="left" rowspan="1" colspan="1">0.8 (&#x02212; 0.5 to 2.1)</td><td align="left" rowspan="1" colspan="1">0.22</td></tr><tr><td align="left" rowspan="1" colspan="1">NO<sub>2</sub></td><td align="center" rowspan="1" colspan="1">15.9 &#x003bc;g/m<sup>3</sup></td><td align="left" rowspan="1" colspan="1">1.7 (0.2 to 3.4)</td><td align="left" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" rowspan="1" colspan="1">PNC</td><td align="center" rowspan="1" colspan="1">11,852/cm<sup>3</sup></td><td align="left" rowspan="1" colspan="1">1.9 (&#x02212; 0.2 to 4.0)</td><td align="left" rowspan="1" colspan="1">0.07</td></tr><tr><td align="left" rowspan="1" colspan="1">PM<sub>2.5</sub></td><td align="center" rowspan="1" colspan="1">11.0 &#x003bc;g/m<sup>3</sup></td><td align="left" rowspan="1" colspan="1">0.6 (&#x02212; 0.8 to 2.0)</td><td align="left" rowspan="1" colspan="1">0.40</td></tr><tr><td align="left" rowspan="1" colspan="1">PM<sub>10</sub></td><td align="center" rowspan="1" colspan="1">17.4 &#x003bc;g/m<sup>3</sup></td><td align="left" rowspan="1" colspan="1">0.0 (&#x02212; 1.3 to 1.3)</td><td align="left" rowspan="1" colspan="1">1.0</td></tr></tbody></table><table-wrap-foot><fn id="tfn6-ehp-117-1373"><label>a</label><p>Inverse-weighted sum of city-specific estimates and 95% CIs from linear regression using log IL-6 concentrations as outcome, with a random effect for subject, using the 24-hr average of air pollutants fitted to the time of IL-6 measurement and adjusting for age, city, BMI, log NT-proBNP, HDL cholesterol, systolic blood pressure, number of MIs, glycosylated hemoglobin, pack-years of cigarette smoking, alcohol intake, history of arrhythmias, heart failure, bronchitis, season, apparent temperature, relative humidity, and hour of visit in city-specific models.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t4-ehp-117-1373" position="float"><label>Table 4</label><caption><p>SNP&#x02013;environment interactions: association between 24-hr average of CO or NO<sub>2</sub> and plasma IL-6 levels by genotype for the analyzed polymorphisms in the genes <italic>IL6</italic>, <italic>FGA</italic>, and <italic>FGB</italic>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/><th colspan="2" align="center" rowspan="1">Change of IL-6<xref ref-type="table-fn" rid="tfn7-ehp-117-1373">a</xref> (% of overall mean per interquartile range increase of pollutant) <hr/></th></tr><tr><th align="left" rowspan="1" colspan="1">SNP</th><th align="center" rowspan="1" colspan="1">Genotype<xref ref-type="table-fn" rid="tfn8-ehp-117-1373">b</xref></th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">CO</th><th align="center" rowspan="1" colspan="1">NO<sub>2</sub></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><italic>IL6</italic> rs2069832</td><td align="center" rowspan="1" colspan="1">1 1</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">2.0 (0.3 to 3.6)</td><td align="center" rowspan="1" colspan="1">3.1 (0.9 to 5.4)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">1 2</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&#x02212; 0.2 (&#x02212; 1.7 to 1.3)</td><td align="center" rowspan="1" colspan="1">1.2 (&#x02212; 0.5 to 3.0)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">2 2</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&#x02212; 2.0 (&#x02212; 4.7 to 0.8)</td><td align="center" rowspan="1" colspan="1">&#x02212; 0.5 (&#x02212; 3.5 to 2.5)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><italic>p</italic>-Value</td><td align="center" rowspan="1" colspan="1">0.03</td><td align="center" rowspan="1" colspan="1">0.09</td></tr><tr><td colspan="5" align="left" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>IL6</italic> rs2069840</td><td align="center" rowspan="1" colspan="1">1 1</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">2.0 (0.3, 3.8)</td><td align="center" rowspan="1" colspan="1">1.8 (&#x02212; 0. 4 to 4.0)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">1 2</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.4 (&#x02212; 0.9, 1.7)</td><td align="center" rowspan="1" colspan="1">1.7 (0.0 to 3.4)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">2 2</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&#x02212; 1.2 (&#x02212; 3.4, 1.1)</td><td align="center" rowspan="1" colspan="1">1.7 (&#x02212; 1.5 to 4.9)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><italic>p</italic>-Value</td><td align="center" rowspan="1" colspan="1">0.04</td><td align="center" rowspan="1" colspan="1">0.93</td></tr><tr><td colspan="5" align="left" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>IL6</italic> rs2069845</td><td align="center" rowspan="1" colspan="1">1 1</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">1.9 (0.2 to 3.5)</td><td align="center" rowspan="1" colspan="1">2.8 (0.5 to 5.1)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">1 2</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&#x02212; 0.1 (&#x02212; 1.5 to 1.4)</td><td align="center" rowspan="1" colspan="1">1.3 (&#x02212; 0.4 to3.1)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">2 2</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&#x02212; 1.6 (&#x02212; 4.3 to 1.2)</td><td align="center" rowspan="1" colspan="1">0.2 (&#x02212; 2.6 to 3.2)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><italic>p</italic>-Value</td><td align="center" rowspan="1" colspan="1">0.31</td><td align="center" rowspan="1" colspan="1">0.26</td></tr><tr><td colspan="5" align="left" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>FGA</italic> rs2070011</td><td align="center" rowspan="1" colspan="1">1 1</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">1.0 (&#x02212; 0.7 to 2.7)</td><td align="center" rowspan="1" colspan="1">2.1 (&#x02212; 0.1 to 4.3)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">1 2</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.7 (0.6 to 2.0)</td><td align="center" rowspan="1" colspan="1">1.6 (&#x02212; 0.1 to 3.3)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">2 2</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.4 (&#x02212; 1.9 to 2.7)</td><td align="center" rowspan="1" colspan="1">1.1 (&#x02212; 1.8 to 4.1)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><italic>p</italic>-Value</td><td align="center" rowspan="1" colspan="1">0.64</td><td align="center" rowspan="1" colspan="1">0.64</td></tr><tr><td colspan="5" align="left" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>FGB</italic> rs1800790</td><td align="center" rowspan="1" colspan="1">1 1</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&#x02212; 0.2 (&#x02212; 1.8 to 1.3)</td><td align="center" rowspan="1" colspan="1">1.0 (&#x02212; 0.9 to 2.9)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">1 2</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">2.1 (0.4 to 3.8)</td><td align="center" rowspan="1" colspan="1">2.8 (0.6 to 5.0)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">2 2</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">4.5 (1.1 to 8.0)</td><td align="center" rowspan="1" colspan="1">4.4 (0.1 to 8.9)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><italic>p</italic>-Value</td><td align="center" rowspan="1" colspan="1">0.02</td><td align="center" rowspan="1" colspan="1">0.19</td></tr></tbody></table><table-wrap-foot><fn id="tfn7-ehp-117-1373"><label>a</label><p>Inverse-variance weighted sum of city-specific estimates and 95% CIs from linear regression using IL-6 concentrations as outcome and an additive genetic model for the genotype, with a random effect by subject, using the 24-hr average of CO or NO<sub>2</sub> fitting to the time of IL-6 measurement, including a genotype&#x02013;CO interaction adjusted for age, city, BMI, log NT-proBNP, HDL cholesterol, systolic blood pressure, number of MIs, glycosylated hemoglobin, pack-years of cigarette smoking, alcohol intake, history of arrhythmias, heart failure, bronchitis, season, apparent temperature, relative humidity, and hour of visit in city-specific models. Interquartile range increase: CO, 0.34 mg/m<sup>3</sup>; NO<sub>2</sub>, 15.9 &#x003bc;g/m<sup>3</sup>.</p></fn><fn id="tfn8-ehp-117-1373"><label>b</label><p>1, major allele; 2, minor allele.</p></fn></table-wrap-foot></table-wrap></floats-group></article>